findmyKOL
Clinical trialNCT02580058CompletedPhase 3Interventional

A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)

SponsorPfizerEnrollment566Ovarian Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

295 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Epic Pharmacy,newcastle Private Hospital

    New Lambton Heights, New South Wales, Australia

  • Newcastle Private Hospital Pty Limited

    Newcastle, New South Wales, Australia

  • Icon Cancer Care Wesley

    Auchenflower, Queensland, Australia

  • Rivercity Pharmacy

    Auchenflower, Queensland, Australia

  • Mater Pharmacy Services

    Brisbane, Queensland, Australia

  • Icon Cancer Care Chermside

    Chermside, Queensland, Australia

  • Clinical Research Unit

    Herston, Queensland, Australia

  • Metro North Hospital and Health Service

    Herston, Queensland, Australia

  • Oncology Pharmacy

    Herston, Queensland, Australia

  • Icon Cancer Care

    South Brisbane, Queensland, Australia

  • Icon Cancer Foundation

    South Brisbane, Queensland, Australia

  • Mater Cancer Care Centre

    South Brisbane, Queensland, Australia

  • Icon Cancer Care Southport

    Southport, Queensland, Australia

  • Cabrini Health Limited

    Brighton, Victoria, Australia

  • Cabrini Health Limited

    Malvern, Victoria, Australia

  • Peter Maccallum Cancer Centre

    Melbourne, Victoria, Australia

  • Pharmacy Department

    Parkville, Victoria, Australia

  • Royal Melbourne Hospital

    Parkville, Victoria, Australia

  • the Royal Women'S Hospital

    Parkville, Victoria, Australia

Austria
  • Medizinische Universitat Graz, Lkh-Univ. Klinikum Graz

    Graz, Austria

  • Medizinische Universitat Innsbruck

    Innsbruck, Austria

Belgium
  • University Hospital Gent

    Ghent, EAST Flanders, Belgium

  • Institut Jules Bordet

    Brussels, Belgium

  • Az Groeninge Hospital

    Kortrijk, Belgium

  • Universitaire Ziekenhuizen Leuven

    Leuven, Belgium

  • Chu de Liege - Sart Tilman

    Liège, Belgium

  • Clinique Et Maternite Sainte Elisabeth

    Namur, Belgium

Canada
  • Tom Baker Cancer Centre

    Calgary, Alberta, Canada

  • Cross Cancer Institute

    Edmonton, Alberta, Canada

  • British Columbia Cancer Agency - Sindi Ahluwalia Hawkins Centre for the Southern Interior

    Kelowna, British Columbia, Canada

  • British Columbia Cancer Agency-Vancouver Centre

    Vancouver, British Columbia, Canada

  • Cancercare Manitoba

    Winnipeg, Manitoba, Canada

  • Health Sciences Centre

    Winnipeg, Manitoba, Canada

  • St. Boniface General Hospital

    Winnipeg, Manitoba, Canada

  • Nova Scotia Health Authority, Qeii Health Sciences Centre

    Halifax, Nova Scotia, Canada

  • Nova Scotia Health Authority, Qeii Health Sciences Centre, Nova Scotia Cancer Centre

    Halifax, Nova Scotia, Canada

  • the Ottawa Hospital

    Ottawa, Ontario, Canada

  • Princess Margaret Cancer Centre

    Toronto, Ontario, Canada

  • Sunnybrook Research Institute

    Toronto, Ontario, Canada

  • Jewish General Hospital

    Montreal, Quebec, Canada

255 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Dec 2015
Primary completion
19 Sept 2018
Completion
12 Jul 2022
Last update posted
10 Jul 2023
Registered enrollment
566
Registry id
NCT02580058

Cross-registrations

EU-CTR / CTIS (EudraCT)2015-003091-77

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.